Plan X
I have to think that management wasn't surprised by their CRL. Except for a short pre adcom pop, when people that matter jumped ship after a seeking alpha article was published, the share price has been hinting at it since the priority review was announced. Certainly they must have known, with a high probability, since the Adcomm failure. The market knew. It barely traded heading into an FDA decision?.If that is the case why would would they be scrambling for a contingency plan. Wouldn't they already have one in place? Aren't good managers expected to be prepared for the likelihood of the worst, when the signs were everywhere? Why the delay to speak to shareholders?